Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence

I Smith - Clinical microbiology reviews, 2003 - Am Soc Microbiol
Tuberculosis (TB), one of the oldest known human diseases. is still is one of the major
causes of mortality, since two million people die each year from this malady. TB has many …

Specific immune-based diagnosis of tuberculosis

P Andersen, ME Munk, JM Pollock, TM Doherty - The Lancet, 2000 - thelancet.com
Current diagnostic tests for tuberculosis based on tuberculin have poor specificity, and both
BCG vaccination and exposure to non-tuberculosis mycobacteria produce a response …

Mycobacterium avium subsp. paratuberculosisin Veterinary Medicine

NB Harris, RG Barletta - Clinical microbiology reviews, 2001 - Am Soc Microbiol
Mycobacterium avium subsp. paratuberculosis (basonym M. paratuberculosis) is the
etiologic agent of a severe gastroenteritis in ruminants known as Johne's disease. Economic …

Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis

AL Sørensen, S Nagai, G Houen, P Andersen… - Infection and …, 1995 - Am Soc Microbiol
A novel immunogenic antigen, the 6-kDa early secretory antigenic target (ESAT-6), from
short-term culture filtrates of Mycobacterium tuberculosis was purified by hydrophobic …

Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG

M Harboe, T Oettinger, HG Wiker… - Infection and …, 1996 - Am Soc Microbiol
ESAT-6 is a secreted protein present in the short-term culture filtrate of Mycobacterium
tuberculosis after growth on a synthetic Sauton medium. ESAT-6 has recently been …

Immune Responses to Bacillus Calmette–Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?

JI Moliva, J Turner, JB Torrelles - Frontiers in immunology, 2017 - frontiersin.org
Mycobacterium tuberculosis (M. tb), the causative agent of tuberculosis (TB), is the current
leading cause of death due to a single infectious organism. Although curable, the broad …

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens

Y Perrie, AR Mohammed, DJ Kirby, SE McNeil… - International journal of …, 2008 - Elsevier
Vaccination remains a key tool in the protection and eradication of diseases. However, the
development of new safe and effective vaccines is not easy. Various live organism based …

Epitope mapping: the first step in developing epitope-based vaccines

JM Gershoni, A Roitburd-Berman, DD Siman-Tov… - BioDrugs, 2007 - Springer
Antibodies are an effective line of defense in preventing infectious diseases. Highly potent
neutralizing antibodies can intercept a virus before it attaches to its target cell and, thus …

Proteomics: new perspectives, new biomedical opportunities

RE Banks, MJ Dunn, DF Hochstrasser, JC Sanchez… - The Lancet, 2000 - thelancet.com
Proeomics-based approaches, which examine the expressed proteins of a tissue or cell
type, complement the genome initiatives and are increasingly being used to address …

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

K Huygen, J Content, O Denis, DL Montgomery… - Nature medicine, 1996 - nature.com
Tuberculosis is the most widespread and lethal infectious disease affecting humans.
Immunization of mice with plasmid DNA constructs encoding one of the secreted …